raised hope of the U.S. economy staging a fast recovery next year. However, investors loading up on beaten-down value names should brace for some volatile swings as risks to the group linger.
The iShares Russell 1000 Value ETF rallied 5.7% last week after Pfizer and BioNTech said Monday that their coronavirus vaccine candidate was more than 90% effective at preventing the coronavirus during a late-stage trial. Value's gain came at the expense of high-flying growth stocks. The iShares Russell 1000 Growth ETF (
Pro China must stop eating bat,dog,cat,snake meat . They should close all biotech labs .They are not smart enough to keep one . Otherwise world should isolate them like North Korea
Pro
Pro nice
Pro
Pro Irradiated the China Joe computer virus from fair and free elections.. nochinajoe